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Abstract The ability of poly(ADP-ribose)polymerase to bind
damaged DNA was assessed by electrophoretic mobility shift
assay. DNA binding domain of poly(ADP-ribose)polymerase
(PARPDBD) binds to synthetic deoxyribonucleotide duplex
10-mer. However, the synthetic deoxyribonucleotide duplex
containing cys-syn thymidine dimer which produces the unwind-
ing of DNA helix structure lost its affinity to PARPDBD. It was
shown that the binding of PARPDBD to the synthetic
deoxyribonucleotide duplex was not affected by O6-Me-dG
which causes only minor distortion of DNA helix structure. This
study suggests that the stabilized DNA helix structure is
important for poly(ADP-ribose)polymerase binding to DNA
breaks, which are known to stimulate catalytic activity of
poly(ADP-ribose)polymerase.
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1. Introduction
Poly(ADP-ribose)polymerase (PARP) is a chromatin-asso-
ciated nuclear enzyme in eukaryotic cells. The binding of
PARP to DNA breaks is known to activate catalytic activity
of the enzyme. The DNA bound, activated PARP transfers
ADP-ribose moiety from nicotinamide adenine dinucleotide
(NAD) to numerous nuclear proteins including PARP itself,
histones, RNA polymerase II, topoisomerase I, DNA polym-
erase K and DNA polymerase L [1,2].
PARP is composed of three functional domains: an N-ter-
minal DNA binding domain that binds to DNA strand breaks
[3], a central automodi¢cation domain and a C-terminal cata-
lytic domain [4,5]. PARP has been thought to play multifunc-
tional roles in various cellular events including DNA repair,
mitotic cell division, stress responses, cytotoxicity, apoptosis
and maintenance of chromosomal stability [6]. The free DNA
end is known as a strong activator of PARP and PARP ac-
tivity is increased by DNA damaging agents that introduce
DNA breaks [7]. N-terminal fragment of PARP containing
DNA binding domain (PARPDBD) comprises two zinc ¢n-
gers that are involved in the recognition of DNA strand
breaks [8]. Work by Benjamin and Gill [9] has shown that
the ability of DNA to stimulate the catalytic activity of
PARP is solely dependent upon the number and type of
strand breaks, not upon the sequence at the binding sites.
They suggested that double-stranded DNA conformation is
important for the activation of PARP. For example, double-
stranded DNA with £ush end stimulates PARP activity ap-
proximately 3-fold more than the DNA fragment with un-
paired nucleotide extending from 3P strand. They also found
that the duplex structure at 5P end is more important for the
PARP activation than the unpaired extension structure at
5P end.
There are numerous studies showing that DNA damage
disrupts the helical structure of DNA duplex. The UV in-
duced photoadducts in DNA were typically known to desta-
bilize the helical structure [10^12]. In this study, we report
that PARP binding to DNA is inhibited by UV induced pho-
toadduct.
2. Materials and methods
2.1. Synthetic deoxynucleotide oligomers
The oligonucleotide, d(CGCATTACGC), was synthesized by the
phosphoramidite method using a DNA synthesizer (Applied Biosys-
tem Model 391, USA). The crude 5P-dimethoxytritylated oligonucleo-
tide was isolated by treating the support with concentrated aqueous
ammonia for 48 h at room temperature. Puri¢cation of the product
was carried out using reverse-phase high performance liquid chroma-
tography followed by desalting in Sephadex G-25 column. Cis-syn
thymidine dimer was produced by irradiating deoxyribonucleotide
10-mer with UV as previously described [13]. Duplex forms were
prepared by dissolving the photochemically modi¢ed strand and com-
plementary strand (adjusted as a stoichiometric 1:1 ratio) in a solu-
tion containing 20 mM Na2PO4 (pH 7.0), 100 mM NaCl. Deoxyri-
bonucleotide 10-mer containing O6-Me-dG was purchased from
Biosynthesis Inc. (USA). The sequences of the synthetic deoxyribonu-
cleotide oligomers employed in this study were presented in Table 1.
The oligomers were end-labeled using [Q-32P]ATP (Amersham Corp.,
UK) and T4 polynucleotide kinase (Boehringer Mannheim, Ger-
many). The 32P-labeled oligomers were collected using Sephadex
G-25 spun column chromatography (Pharmacia LKB Biotechnology
Inc., USA). Single- and double-stranded deoxyribonucleotide oligo-
mers used as competitor DNA in the electrophoretic mobility shift
assay were supplied by Genotech Inc. (South Korea). The competitor
supercoiled pGEM3 plasmid DNA was puri¢ed using QIAGEN plas-
mid Maxi Kit (USA). Care was taken during the preparation of plas-
mid DNA to avoid the generation of nicked circular or linear plasmid
DNA. The preparation contained routinely s 90% supercoiled form
of DNA as assessed by relative band intensities after electrophoresis
in agarose gel through ethidium bromide staining.
2.2. Preparation of DNA binding domain of PARP
The entire DNA binding domain of PARP (PARPDBD) was pre-
pared by PCR using the primers of 5P-GGGCGGATCCTGGCG-
GAGTCTTCGG-3P (primer A, BamHI site was underlined) and 5P-
GGGCGGATCCCCATCCACCTCATCG-3P (primer B, BamHI site
was underlined). The pGEM7 plasmid (Promega, USA) in which full
length human PARP cDNA was inserted in XbaI site was used as
DNA template. The cDNA fragment encoding two zinc ¢nger do-
mains of PARP was approximately 700 bp in length and was ampli-
¢ed by PCR using the primers A and B. The resulting fragment was
cloned into BamHI site of pET-21c expression vector (Novagen,
USA) to construct pET-739 and E. coli BL21(DE3) cells were trans-
formed with the vector construct. The expression of the cloned gene
was induced by incubating cells in the media containing 0.4 mM
isopropyl-beta-D-thiogalactopyranoside (IPTG) for 3 h. PARPDBD
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was puri¢ed using Ni-NTA column (Qiagen, USA). The purity of
human PARPDBD isolated from E. coli cells was examined by 12%
SDS-PAGE [14]. Immunoblot analysis was also carried out using
polyclonal antibody against N-terminal fragment of human PARP
(Santa Cruz Biotechnology Inc., USA) as a probe [15].
2.3. Electrophoretic mobility shift assay
The electrophoretic mobility shift assay was performed as described
by Blier et al. [16] with slight modi¢cation. DNA binding was per-
formed in a ¢nal volume of 20 Wl of a reaction bu¡er containing
10 mM Tris (pH 7.5), 150 mM NaCl, 1 mM DTT, 0.01% Nonidet
P-40 and 2% polyvinyl alcohol. The 32P-labeled deoxyribonucleotide
oligomers (approximately 20 000 cpm, 50 femtomole) were added to
the reaction mixture together with 3.25 pmole of competitor oligo-
mers. To the reaction mixture, 4 Wg of PARPDBD protein was then
added and the preparation was incubated for 30 min at room temper-
ature. Each 10 Wl of sample preparation was loaded directly onto
premade 8% non-denaturing polyacrylamide minigels (BioRad,
USA) and the electrophoresis was performed at 4‡C. The mobility
shift of 32P-labeled DNA after its binding to PARPDBD was moni-
tored by autoradiography.
3. Results and discussion
The recombinant protein, PARPDBD containing two zinc
¢nger domains (amino acids 1^215) migrated to the distance
corresponding to its molecular weight (V29 kDa) on 12%
SDS-polyacrylamide gels (Fig. 1A and B). Immunoblot anal-
ysis identi¢ed the band as PAPRDBD (Fig. 1C). In Fig. 2A,
the ability of di¡erent forms of DNAs to compete with 32P-
labeled oligomer duplex was assessed by electrophoretic mo-
bility shift assay. It was shown that PARPDBD preferentially
binds to double-stranded DNA. Double-stranded deoxyribo-
nucleotide oligomers apparently competed with the labeled
deoxynucleotide oligomer duplex and inhibited the complex
formation between the labeled duplex and PARPDBD. Sin-
gle-stranded oligomer and supercoiled DNA did not compete
with the labeled oligomer duplex. The double-stranded deox-
yribonucleotide 10-mer was known to be su⁄cient in length
for the activation of PARP since the double-stranded DNA
fragment longer than 8 base pairs was reported to act as a full
activator of PARP [17].
While the direct participatory role of PARP during DNA
repair process is not available, it has been suggested that
PARP binding to DNA breaks produced by DNA damaging
agents may have other functions important for the survival of
damaged cells. The binding of PARP to the sites of DNA
strand breaks may protect the nicked sites from nucleases,
DNA binding proteins and other small DNA molecules.
PARP may protect DNA by preventing recombination events
before DNA repair. The PARP binding to DNA may as well
facilitate survival responses in damaged cells by association
with nuclear proteins necessary for DNA repair such as
DNA ligase III, DNA polymerases, p53, XRCCI and DNA
dependent protein kinase [18]. This study was initiated to
examine the e¡ects of DNA damages on the binding ability
of PARP to DNA. With such a study, we attempted to eval-
uate the e¡ects of DNA damages on PARP activation during
cellular recovery from DNA damage.
Our data showed that the PARPDBD forms a speci¢c com-
plex with 32P-labeled deoxyribonucleotide oligomer duplex.
However, the binding of PARP to the duplex was suppressed
if the deoxyribonucleotide oligomer duplex contained cis-syn
thymidine dimer, a major class of cytotoxic, mutagenic and
carcinogenic DNA lesion induced by UV light (Fig. 2C). It is
unlikely that 10-mer duplex containing cis-syn thymidine
dimer denatured into single-stranded 10-mer during the elec-
trophoretic mobility shift assay and lost its a⁄nity with
PARPDBD. In an independent control experiment, we found
that the structural stability of the modi¢ed duplex was not
altered during electrophoretic mobility shift assay. The elec-
trophoretic mobility of modi¢ed duplex under the same ex-
perimental condition as in Fig. 2C was compared with that of
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Table 1
Sequences of synthetic deoxyribonucleotide oligomersa
Name Sequence
10-mer duplex I 5P-(CGCATTACGC)-3P
3P-(GCGTAATGCG)-5P
Double-stranded 10-mer competitor 5P-(GCGTTAACGC)-3P
3P-(CGCAATTGCG)-5P
Single-stranded 10-mer competitor 5P-(CGCATTACGC)-3P
10-mer duplex I w/cis-synb 5P-(CGCATTACGC)-3P
3P-(GCGTAATGCG)-5P
10-mer duplex II w/O6-Me-dGc 5P-(GCGTCGACGC)-3P
3P-(CGCAGCTGCG)-5P
10-mer duplex II 5P-(GCGTCGACGC)-3P
3P-(CGCAGCTGCG)-5P
aAll the synthetic oligomers except cold competitor oligomers were
5P end-labeled with 32P.
bcis-syn denotes cyclobutane pyrimidine photodimer of thymidylyl
(3P-5P) thymidine in which cis refers to the relative stereochemistry
of the two methyl groups and syn to the relative orientation of the
two C4 carbonyl groups.
cO6-Me-dG denotes methylated guanosine at O6 position.
Fig. 1. Puri¢cation of 29 kDa poly(ADP-ribose)polymerase DNA
binding domain (PARPDBD). A: Schematic representation of
PARPDBD and zinc ¢ngers. B: A⁄nity puri¢ed PARPDBD was
analyzed in 12% SDS-PAGE. Lane 1, size markers (Sigma); lane 2,
cell lysate of E. coli cells before the induction of cloned human
PARPDBD gene; lane 3, cell lysate of IPTG induced E. coli cells
expressing human PARPDBD; lane 4, PARPDBD was a⁄nity puri-
¢ed using Ni-NTA a⁄nity column. C: The puri¢ed PARPDBD was
transferred on the nitrocellulose membrane and probed with poly-
clonal antibody against N-terminal fragment of PARP for immuno-
blot analysis. Arrowheads in B and C indicate 29 kDa PARPDBD.
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the same duplex under a known condition that maintains the
structural stability of the duplex. The stable solution structure
of the control duplex containing cis-syn thymidine dimer has
been shown in the previous study using NMR [13]. The modi-
¢ed duplex showed the same electrophoretic mobility as the
control duplex, while the single-stranded deoxyoligonucleotide
10-mer migrated farther distance on polyacrylamide gels (data
not shown). Thus mobility shift of the labeled 10-mer duplex
II containing cis-syn thymidine dimer does not seem to be
related with the structural change of duplex stability during
the assay. The suppression of PARP binding to the labeled
oligomer probe seemed to be correlated with the unwinding of
deoxynucleotide oligomer duplex in the vicinity of cis-syn thy-
midine dimer. Recent NMR studies have shown that Watson-
Crick duplex is destabilized by cis-syn thymidine dimer that
disrupts the pi-stacking to the 5P side of the thymidine dimer
[10] and distort the phosphodiester backbone at 3P to the
dimer [11]. Thus it was known that the helical structure of
the duplex containing the cis-syn thymidine dimer was un-
wound by V15‡ [12] and bent by 9‡ [13].
In contrast, PARP forms a stable complex with self-com-
plementary deoxyribonucleotide oligomer duplex containing
O6-Me-dG (Fig. 2B). The O6-Me-dG is one of the lesions
introduced into DNA after treatment with methylating agents
[19]. Molecular mechanical studies have shown that O6-Me-
dG exhibits only minor distortion of DNA helix except a
dispersed phosphodiester backbone [20].
PARP binds to DNA interruptions produced by DNA
damaging agents and undergoes a rapid automodi¢cation
with the synthesis of long branched polymers of highly neg-
ative charged poly(ADP-ribose). The relevant function of
PARP in the cellular recovery from DNA damage is still un-
known. Our ¢nding might provide some insight into the
mechanism of di¡erent cellular responses to di¡erent DNA
damages.
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Fig. 2. Binding of poly(ADP-ribose)polymerase DNA binding do-
main (PARPDBD) to double-stranded DNA. A: PARPDBD was
incubated with 32P-labeled 10-mer duplex I with di¡erent forms of
unlabeled competitors. B: The ability of PARPDBD binding to de-
oxyribonucleotide 10-mer duplex containing O6-Me-dG. 32P-labeled
10-mer duplex II with or without O6-Me-dG was incubated with
PARPDBD. The binding of PARPDBD with labeled 10-mer du-
plexes was examined by electrophoretic mobility shift assay and 32P-
labeled oligomer-PARPDBD complex was visualized by autoradiog-
raphy. C: 32P-labeled 10-mer duplex I with or without cis-syn thy-
midine dimer was incubated with PARPDBD. Arrowheads in B and
C indicate 32P-labeled oligomer-PARPDBD complex.
W.S. Yang et al./FEBS Letters 449 (1999) 33^35 35
